Keurig Dr Pepper Inc Forecast, price target & analysts
Keurig Dr Pepper Inc Target price 2025 - Analyst rating & recommendation
Keurig Dr Pepper Inc Classifications & Recommendation:
Keurig Dr Pepper Inc Price Target
| Target Price | $38.41 |
| Price | $33.61 |
| Potential | 14.29% |
| Number of Estimates | 17 |
| 17 Analysts have issued a price target Keurig Dr Pepper Inc 2026 . The average Keurig Dr Pepper Inc target price is $38.41. This is 14.29% higher than the current stock price. The highest price target is $42.00 24.96% , the lowest is $34.00 1.16% . | |
| A rating was issued by 19 analysts: 10 Analysts recommend Keurig Dr Pepper Inc to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Keurig Dr Pepper Inc stock has an average upside potential 2026 of 14.29% . Most analysts recommend the Keurig Dr Pepper Inc stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2028
14 Analysts have issued a sales forecast Keurig Dr Pepper Inc 2025 . The average Keurig Dr Pepper Inc sales estimate is $16.1b . This is 5.03% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $16.3b 5.95% , the lowest is $15.8b 3.04% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $15.4b | 3.62% |
|---|---|---|
| 2025 | $16.1b | 5.03% |
| 2026 | $16.8b | 3.95% |
| 2027 | $17.4b | 3.85% |
| 2028 | $17.8b | 2.04% |
12 Analysts have issued an Keurig Dr Pepper Inc EBITDA forecast 2025. The average Keurig Dr Pepper Inc EBITDA estimate is $4.8b . This is 12.21% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.0b 16.73% , the lowest is $4.2b 1.65% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $4.3b | 9.68% |
|---|---|---|
| 2025 | $4.8b | 12.11% |
| 2026 | $5.1b | 6.10% |
| 2027 | $5.4b | 5.02% |
| 2028 | $5.3b | 0.77% |
EBITDA Margin
| 2024 | 28.04% | 5.84% |
|---|---|---|
| 2025 | 29.93% | 6.73% |
| 2026 | 30.55% | 2.07% |
| 2027 | 30.90% | 1.15% |
| 2028 | 30.05% | 2.75% |
6 Keurig Dr Pepper Inc Analysts have issued a net profit forecast 2025. The average Keurig Dr Pepper Inc net profit estimate is $2.7b . This is 86.39% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.8b 94.52% , the lowest is $2.4b 70.48% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $1.4b | 32.26% |
|---|---|---|
| 2025 | $2.7b | 86.39% |
| 2026 | $2.9b | 8.46% |
| 2027 | $3.1b | 6.00% |
| 2028 | $3.4b | 10.64% |
Net Margin
| 2024 | 9.28% | 34.63% |
|---|---|---|
| 2025 | 16.47% | 77.49% |
| 2026 | 17.18% | 4.31% |
| 2027 | 17.54% | 2.10% |
| 2028 | 19.02% | 8.44% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
6 Analysts have issued a Keurig Dr Pepper Inc forecast for earnings per share. The average Keurig Dr Pepper Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $1.96 . This is 86.67% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $2.04 94.29% , the lowest is $1.79 70.48% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $1.05 | 32.26% |
|---|---|---|
| 2025 | $1.96 | 86.67% |
| 2026 | $2.12 | 8.16% |
| 2027 | $2.25 | 6.13% |
| 2028 | $2.49 | 10.67% |
P/E ratio
| Current | 31.96 | 63.56% |
|---|---|---|
| 2025 | 17.17 | 46.28% |
| 2026 | 15.83 | 7.80% |
| 2027 | 14.94 | 5.62% |
| 2028 | 13.50 | 9.64% |
Based on analysts' sales estimates for 2025, the Keurig Dr Pepper Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 3.87 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 2.83 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 4.06 | 5.73% |
|---|---|---|
| 2025 | 3.87 | 4.79% |
| 2026 | 3.72 | 3.80% |
| 2027 | 3.58 | 3.71% |
| 2028 | 3.51 | 2.00% |
P/S ratio
| Current | 2.97 | 4.24% |
|---|---|---|
| 2025 | 2.83 | 4.79% |
| 2026 | 2.72 | 3.80% |
| 2027 | 2.62 | 3.71% |
| 2028 | 2.57 | 2.00% |
Keurig Dr Pepper Inc...
Current Keurig Dr Pepper Inc Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays | Overweight ➜ Overweight | Unchanged | Feb 27 2025 |
| Morgan Stanley | Equal-Weight ➜ Equal-Weight | Unchanged | Feb 26 2025 |
| JP Morgan | Overweight ➜ Overweight | Unchanged | Feb 26 2025 |
| Barclays | Overweight ➜ Overweight | Unchanged | Jan 17 2025 |
| UBS | Buy ➜ Buy | Unchanged | Jan 16 2025 |
| TD Cowen | Hold ➜ Hold | Unchanged | Jan 08 2025 |
| Piper Sandler | Neutral | Initiated | Jan 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Barclays: Overweight ➜ Overweight
|
Feb 27 2025 |
|
Unchanged
Morgan Stanley: Equal-Weight ➜ Equal-Weight
|
Feb 26 2025 |
|
Unchanged
JP Morgan: Overweight ➜ Overweight
|
Feb 26 2025 |
|
Unchanged
Barclays: Overweight ➜ Overweight
|
Jan 17 2025 |
|
Unchanged
UBS: Buy ➜ Buy
|
Jan 16 2025 |
|
Unchanged
TD Cowen: Hold ➜ Hold
|
Jan 08 2025 |
|
Initiated
Piper Sandler: Neutral
|
Jan 07 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
